Home Trending Stocks Aethlon Medical, Inc. (AEMD) Stock Skyrockets Following Success of Hemopurifier Treatment in...

Aethlon Medical, Inc. (AEMD) Stock Skyrockets Following Success of Hemopurifier Treatment in Covid-19 Patient

Aethlon Medical, Inc. (AEMD) stock prices were up by a marginal 0.45% as of the market closing on June 8th, 2021, bringing the price per share up to USD$2.21 at the end of the trading day. After-hours trading saw the stock skyrocket by an astounding 92.31%, bringing it up to USDS$4.25.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

EUA for Hemopurifier

The company recently announced the positive results from use of Aethlon Hemopurifier in treating two patients who were critically ill with Covid-19, with neither patient expected to survive. The dire circumstances merited the granting of emergency use authorization (EUA) by the FDA. That is to say, the treatment has not yet been fully approved by the U.S. Food and Drug Administration, but was allowed because of the absence of any other viable options.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

  Read More

Hemopurifier Treatment

The first patient was administered the Hemopurifier treatment daily, with adequate tolerance of the procedure and no signs of allergic reaction, thrombotic complications, or hemolysis. The treatment regimen resulted in the patient being observed without any demonstrable Covid-19 viremia, the active circulation of the virus in the bloodstream. Viremia has been associated with disease severity and the progression to multi-organ failure.

Efficacy of Treatment

The treatment resulted in improvements in Covid-19 associated coagulopathy (CAC), lung injury, inflammation, and tissue injury. Consequently, the company is confident that the improvements are a reflection of the treatment’s ability to remove exosome with noxious microRNA cargo. This removal of exosomes is what AEMD’s posits contributed the patient’s recover.

Results of Hemopurifier

The patient exhibited decreases in total exosomal concentration in the patient as compared to reports from before the administering of the Hemopurifier treatment. The patient’s lung injury also showed signs of having improved as a result of the treatment. The regimen included eight Hemopurifier treatments, none of which had any complication. The patient was ultimately weaned from a ventilator and eventually discharged from the hospital.

Scope of Treatment

These findings support the claim that the benefits of the Hemopurifier treatment in Covid-19 has the potential to be useful beyond virus removal in its capacity to eliminate exosomes. As the treatment is being evaluated for its efficacy in removing exosomes to treat patients with cancer, the treatment of the Covid-19 patient shows that exosomes are also involved in the cell-to-cell spread of Covid-19 infection and its associated inflammation coagulopathy, and complement activation.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for AEMD

With the world hurtling towards global immunizations, AEMD is poised to capitalize on these efforts with the commercialization and proliferation of its Hemopurifier treatment. Current and potential investors are hopeful that management will leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam